Terms: = Prostate cancer AND EIF4A2, DDX2B, 1974, ENSG00000156976, EIF4F, BM-010, EIF4A
184 results:
1. Magnetic resonance fingerprinting based comprehensive quantification of T1 and T2 values of the background prostatic peripheral zone: Correlation with clinical and demographic features.
de Oliveira Correia ET; Qiao PL; Griswold MA; Chen Y; Bittencourt LK
Eur J Radiol; 2023 Jul; 164():110883. PubMed ID: 37209463
[TBL] [Abstract] [Full Text] [Related]
2. First-line Systemic Treatment Options for Metastatic Castration-Sensitive prostate cancer: A Living Systematic Review and Network Meta-analysis.
Riaz IB; Naqvi SAA; He H; Asghar N; Siddiqi R; Liu H; Singh P; Childs DS; Ravi P; Hussain SA; Murad MH; Boorjian SA; Sweeney C; Van Allen EM; Bryce AH
JAMA Oncol; 2023 May; 9(5):635-645. PubMed ID: 36862387
[TBL] [Abstract] [Full Text] [Related]
3. Long-term survival trends in solid cancers in the Nordic countries marking timing of improvements.
Hemminki K; Försti A; Liska V; Kanerva A; Hemminki O; Hemminki A
Int J Cancer; 2023 May; 152(9):1837-1846. PubMed ID: 36571455
[TBL] [Abstract] [Full Text] [Related]
4. Evaluating the Downstream Revenues of a Self-Pay Bi-Parametric prostate MRI Program.
Parikh KD; Declouette B; Chen M; Rao S; Smith DA; Bittencourt LK; Paspulati RM; Ramaiya NH; Tirumani SH
Urology; 2023 Jan; 171():109-114. PubMed ID: 36195163
[TBL] [Abstract] [Full Text] [Related]
5. METTL3 preferentially enhances non-m
Wei X; Huo Y; Pi J; Gao Y; Rao S; He M; Wei Q; Song P; Chen Y; Lu D; Song W; Liang J; Xu L; Wang H; Hong G; Guo Y; Si Y; Xu J; Wang X; Ma Y; Yu S; Zou D; Jin J; Wang F; Yu J
Nat Cell Biol; 2022 Aug; 24(8):1278-1290. PubMed ID: 35927451
[TBL] [Abstract] [Full Text] [Related]
6. Skene's Gland Malignancy: A Case Report and Systematic Review.
Slopnick EA; Bagby C; Mahran A; Nagel C; Garcia J; El-Nashar S; Hijaz AK
Urology; 2022 Jul; 165():36-43. PubMed ID: 35192863
[TBL] [Abstract] [Full Text] [Related]
7. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
Attard G; Murphy L; Clarke NW; Cross W; Jones RJ; Parker CC; Gillessen S; Cook A; Brawley C; Amos CL; Atako N; Pugh C; Buckner M; Chowdhury S; Malik Z; Russell JM; Gilson C; Rush H; Bowen J; Lydon A; Pedley I; O'Sullivan JM; Birtle A; Gale J; Srihari N; Thomas C; Tanguay J; Wagstaff J; Das P; Gray E; Alzoueb M; Parikh O; Robinson A; Syndikus I; Wylie J; Zarkar A; Thalmann G; de Bono JS; Dearnaley DP; Mason MD; Gilbert D; Langley RE; Millman R; Matheson D; Sydes MR; Brown LC; Parmar MKB; James ND;
Lancet; 2022 Jan; 399(10323):447-460. PubMed ID: 34953525
[TBL] [Abstract] [Full Text] [Related]
8. Overall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysis.
Gaudino M; Hameed I; Farkouh ME; Rahouma M; Naik A; Robinson NB; Ruan Y; Demetres M; Biondi-Zoccai G; Angiolillo DJ; Bagiella E; Charlson ME; Benedetto U; Ruel M; Taggart DP; Girardi LN; Bhatt DL; Fremes SE
JAMA Intern Med; 2020 Dec; 180(12):1638-1646. PubMed ID: 33044497
[TBL] [Abstract] [Full Text] [Related]
9. WD Repeat Domain 77 Protein Regulates Translation of E2F1 and E2F3 mRNA.
Altayyar MA; Sheng X; Wang Z
Mol Cell Biol; 2020 Nov; 40(24):. PubMed ID: 33020149
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract] [Full Text] [Related]
11. UVEAL METASTASIS BASED ON PATIENT AGE IN 1,111 PATIENTS: Comparison of Clinical Features and Outcomes Per Age Category.
Shields CL; Acaba-Berrocal LA; Selzer EB; Mayro EL; Newman JH; Malik K; Welch RJ; Shields JA
Retina; 2020 Feb; 40(2):204-213. PubMed ID: 31972789
[TBL] [Abstract] [Full Text] [Related]
12. The androgen receptor regulates a druggable translational regulon in advanced prostate cancer.
Liu Y; Horn JL; Banda K; Goodman AZ; Lim Y; Jana S; Arora S; Germanos AA; Wen L; Hardin WR; Yang YC; Coleman IM; Tharakan RG; Cai EY; Uo T; Pillai SPS; Corey E; Morrissey C; Chen Y; Carver BS; Plymate SR; Beronja S; Nelson PS; Hsieh AC
Sci Transl Med; 2019 Jul; 11(503):. PubMed ID: 31366581
[TBL] [Abstract] [Full Text] [Related]
13. Regulation of eif4f Translation Initiation Complex by the Peptidyl Prolyl Isomerase FKBP7 in Taxane-resistant prostate cancer.
Garrido MF; Martin NJ; Bertrand M; Gaudin C; Commo F; El Kalaany N; Al Nakouzi N; Fazli L; Del Nery E; Camonis J; Perez F; Lerondel S; Le Pape A; Compagno D; Gleave M; Loriot Y; Désaubry L; Vagner S; Fizazi K; Chauchereau A
Clin Cancer Res; 2019 Jan; 25(2):710-723. PubMed ID: 30322877
[TBL] [Abstract] [Full Text] [Related]
14. The oncoprotein Myc controls the phosphorylation of S6 kinase and AKT through protein phosphatase 2A.
Chellini L; Monteleone V; Lombari M; Caldarola S; Loreni F
J Cell Biochem; 2018 Dec; 119(12):9878-9887. PubMed ID: 30132971
[TBL] [Abstract] [Full Text] [Related]
15. Eukaryotic Translation Initiation Factor 4 Gamma 1 (eIF4G1) is upregulated during prostate cancer progression and modulates cell growth and metastasis.
Jaiswal PK; Koul S; Shanmugam PST; Koul HK
Sci Rep; 2018 May; 8(1):7459. PubMed ID: 29748619
[TBL] [Abstract] [Full Text] [Related]
16. [Update of the Gleason system and other prognostic pathological data in prostate cancer: Tumor load.].
García-González R; García-Navas R; Montáns-Araújo J
Arch Esp Urol; 2016 Dec; 69(10):669-673. PubMed ID: 28042788
[TBL] [Abstract] [Full Text] [Related]
17. A Phase II, Randomized, Open-Label Study of Neoadjuvant Degarelix versus LHRH Agonist in prostate cancer Patients Prior to Radical prostatectomy.
Sayyid RK; Evans A; Hersey K; Maloni R; Hurtado-Coll A; Kulkarni G; Finelli A; Zlotta AR; Hamilton R; Gleave M; Fleshner NE
Clin Cancer Res; 2017 Apr; 23(8):1974-1980. PubMed ID: 27756786
[No Abstract] [Full Text] [Related]
18. [THE EVOLUTION OF MARKERS OF prostate cancer].
Peshkov MN; Generozov EV; Kostryukova ES
Klin Lab Diagn; 2016 Mar; 61(3):132-40. PubMed ID: 27506103
[TBL] [Abstract] [Full Text] [Related]
19. [Role of eukaryotic translation initiation factor 4G in tumor].
Zhang S; Huang N; Pan X; Zang JL; Guan XX; Zhang JH; Liu LC; Lei XY
Sheng Li Xue Bao; 2016 Apr; 68(2):207-14. PubMed ID: 27108909
[TBL] [Abstract] [Full Text] [Related]
20. Racial-Sex Disparities--A Challenging Battle Against cancer Mortality in the USA.
Fu WJ
J Racial Ethn Health Disparities; 2015 Jun; 2(2):158-66. PubMed ID: 26863334
[TBL] [Abstract] [Full Text] [Related]
[Next]
